Caprion Saama-Led Consortium Seeks Data-Driven Answers to COVID-19 The newly launched EndPandemic National Data Consortium brings together seven life sciences and bioinformatics firms in search of treatments and vaccines. Caprion, HistoGeneX Combining to Form New Firm The new company, whose name was not disclosed, will provide preclinical and clinical immune monitoring and biomarker services to biopharma companies. Caprion Biosciences Buys Immune Monitoring Firm Serametrix Caprion said that the acquisition helps it acquire expertise in the analysis of myeloid-derived suppressor cells and expand its geographic coverage. Roche Partners with Biognosys, Caprion to Demonstrate Proteomics Readiness for Clinical Trials Premium Roche ran a mock clinical trial in which it used DIA mass spec and targeted proteomics to profile 30 colorectal cancer samples under GCP conditions. Caprion Acquires Primity Bio According to Caprion, the company plans to use Primity's assets to expand its existing immunology and molecular profiling business. Aug 24, 2017 Caprion Collaborating With FNIH to Test Alzheimer's Protein Panel Premium Aug 23, 2017 Caprion Collaborating with FNIH on Alzheimer's Biomarkers Sep 15, 2016 Caprion Aims to Expand Immune Monitoring Business With European Acquisition Premium Sep 13, 2016 Caprion Acquires ImmuneHealth's Immune Monitoring Laboratory Jul 22, 2016 Caprion Eyeing Acquisitions, Geographic Expansion After Purchase by GHO Capital Premium Jul 20, 2016 Caprion Acquired by GHO Capital Feb 4, 2016 Results From Merck Collaboration Have Caprion Eyeing Clinical Role for ImmuneCarta Platform Premium Feb 5, 2015 Caprion Licenses Indi's Xpresys as Part of Larger Clinical Push Premium Feb 3, 2015 Caprion Takes Licenses to Indi's Xpresys Lung Test Dec 31, 2014 Abcodia Taps Caprion's Mass Spec Proteomics Platforms for Cancer Biomarker Development Premium Dec 10, 2014 Additional Members Join UK Cancer Consortium Oct 18, 2013 InDi Publishes Discovery, Validation Data Underpinning Forthcoming Proteomic Lung Cancer Dx Premium Feb 22, 2013 Caprion Leading $21M Clinical Biomarker and Personalized Medicine Development Project Premium Feb 15, 2013 Quebec Launches $21M Personalized Medicine Partnership Jan 4, 2013 2012 Sees Rise of Targeted Proteomics and DIA-MS, Continued Clinical Push by Big Industry Players Premium Dec 14, 2012 Myriad RBM Collaborating with Sanofi on Protein Biomarkers for Diabetes Diagnosis, Drug Response Premium Jul 27, 2012 MRM-MS 'Core' to Caprion's Protein Dx Strategy in Wake of Acquisition by Chicago Growth Partners Premium Jul 19, 2012 Thallion Sells Stake in Caprion for $4.5M Oct 22, 2010 Caprion Identifies Protein Biomarkers for Predicting Patient Response to New Hepatitis C Drug Premium Jan 22, 2010 Caprion Buys PPD's Biomarker Business Load More Breaking News Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.